Aquatic Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Aquatic Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,089	Closed	-$38.1K	–	1605
2026 Q1	$38.1K	Sell	16,089 -85,420	-84%	-$296K	﹤0.01%	1203
2025 Q4	$526K	Buy	101,509 +81,893	+417%	+$397K	0.01%	717
2025 Q3	$82.8K	Sell	19,616 -37,816	-66%	-$176K	﹤0.01%	1238
2025 Q2	$210K	Buy	57,432 +14,161	+33%	+$52.8K	﹤0.01%	1007
2025 Q1	$187K	Buy	43,271 +8,550	+25%	+$34.5K	﹤0.01%	950
2024 Q4	$111K	Buy	+34,721	New	+$116K	﹤0.01%	1047
2023 Q2	–	Sell	-13,900	Closed	-$30K	–	1643
2023 Q1	$30K	Buy	+13,900	New	+$34.3K	﹤0.01%	980
2022 Q4	–	Sell	-4,300	Closed	-$14K	–	1693
2022 Q3	$14K	Buy	4,300 +1,100	+34%	+$4.97K	﹤0.01%	1032
2022 Q2	$16K	Buy	+3,200	New	+$19.7K	0.01%	881

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aquatic Capital Management's ORGO Position: Q2 2026 in Review

Aquatic Capital Management sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 16,089 shares — an estimated $38.1K sold.

Aquatic Capital Management first reported a position in ORGO in Q2 2022 and held it in 9 quarters. The position peaked at $526K in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Aquatic Capital Management reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
Aquatic Capital Management sold 16,089 Organogenesis Holdings shares in Q2 2026, an estimated $38.1K.
Aquatic Capital Management first reported a position in Organogenesis Holdings in Q2 2022 and held it in 9 quarters.
Aquatic Capital Management's Organogenesis Holdings position peaked at $526K in Q4 2025.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.